6505--Ticagrelor Tablets

The Department of Veterans Affairs National Acquisition Center seeks a single-award supply contract for Ticagrelor Tablets across two distinct packaging groups, with proposals due September 17, 2026. The procurement is unrestricted with no set-aside applied.

Place of performance encompasses VA facilities, Department of Defense ordering activities, Indian Health Service, Bureau of Prisons, Captain James A. Lovell Federal Health Care Center, and State Veterans Homes. Products will be distributed through existing Pharmaceutical Prime Vendor programs.

Offerors must submit pricing for either Group I (60mg and 90mg tablets in unit-of-use 60-count bottles and bulk 500-count or 1,000-count bottles) or Group II (60mg and 90mg unit-of-use 60-count bottles only), with pricing required for the base year and four one-year option periods. Only one group will be awarded based on lowest evaluated price. The base year estimated annual requirement totals 180,247 bottles. All prices must include a 0.5% Cost Recovery Fee and comply with Federal Ceiling Price requirements if applicable under 38 U.S.C. 8126.

Manufacturers must maintain FDA current Good Manufacturing Practices status, provide unique 11-digit NDC numbers, comply with Drug Supply Chain Security Act serialization and EPCIS filing requirements, include GS1-128 or HIBCC bar code labeling, and meet USP/NF quality standards. Non-manufacturer offerors must submit a Letter of Commitment from their manufacturer and maintain the same manufacturer throughout contract performance unless the Contracting Officer approves changes. The contract includes a 60-calendar-day implementation period followed by a one-year base ordering period and four optional one-year renewal periods. Non-small business offerors with contracts exceeding $900,000 are subject to small business subcontracting plan requirements.